Article
LINE-1 ORF1p is a shared and immunogenic antigen in cancer
2025-06-17
Abstract excerpt
<h4>Background</h4> Recent clinical trials are beginning to show the potential for therapeutic cancer vaccines directed against tumor associated antigens. However, there is a limited set of well-defined antigens that are shared across tumors. Noncanonical coding elements in the genome that are usually silenced in normal cells potentially represent a rich source of “dark” antigens when expressed and presented to t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd012e57-3164-573a-943e-20cc1546628b
- DOI
- 10.1101/2025.06.11.659092
